Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE

Patrick Schöffski*, Michaela Kubickova, Agnieszka Wozniak, Jean Yves Blay, Sandra J. Strauss, Silvia Stacchiotti, Tomasz Switaj, Veit Bücklein, Michael G. Leahy, Antoine Italiano, Nicolas Isambert, Maria Debiec-Rychter, Raf Sciot, Che Jui Lee, Frank M. Speetjens, Axelle Nzokirantevye, Anouk Neven, Bernd Kasper

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE'. Together they form a unique fingerprint.

Medicine & Life Sciences